Australia tightens blood screening against pathogens:
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration (TGA) has instructed the Australian Red Cross Blood Service to introduce stricter controls for blood monitoring to guard against newly-emerging pathogens. These include SARS, the West Nile virus and the Dengue Fever virus. These pathogens have only recently been regarded as relevant to the blood transfusion and include infectious agents that were previously not considered to be transfusion transmitted. They may also contain other agents that require further study before their risk to the blood supply can be assessed, said the TGA.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.